On ECHEMI
Home > Drugs > Kaifeng Pharmaceutical (GROUP) Co., Ltd.
Kaifeng Pharmaceutical (GROUP) Co., Ltd.
  • Founded in:

    2003-09-26
  • Country:

    China China
  • Address:

    No. 1, Yunan Street, Kaifeng City
  • Tax NO.:

    914102007551588773
  • Registered Funds:

    204.568562 million yuan
  • Email:

Related Drugs
Pralidoxime chloride injection
Pralidoxime chloride
Name Description Content CAS NO. Registered Holders
Pralidoxime Chloride

This product is a hydroxyl compound. Its quaternary ammonium group can tend to the cationic site of the phosphorylated cholinesterase that has lost its activity and is combined with the organophosphorus insecticide. Its nucleophilic group can directly combine with the phosphorylated group of cholinesterase and then detach from the cholinesterase together, so that the cholinesterase returns to its original state and regains its activity. It has no resurrection effect on the cholinesterase inhibited by chronic organophosphorus insecticide poisoning. This product has a significant effect on the nicotine-like symptoms caused by organophosphorus insecticides, but a weak effect on the phytosterol-like symptoms, and no significant effect on the symptoms of the central nervous system.

More

This product is a hydroxyl compound. Its quaternary ammonium group can tend to the cationic site of the phosphorylated cholinesterase that has lost its activity and is combined with the organophosphorus insecticide. Its nucleophilic group can directly combine with the phosphorylated group of cholinesterase and then detach from the cholinesterase together, so that the cholinesterase returns to its original state and regains its activity. It has no resurrection effect on the cholinesterase inhibited by chronic organophosphorus insecticide poisoning. This product has a significant effect on the nicotine-like symptoms caused by organophosphorus insecticides, but a weak effect on the phytosterol-like symptoms, and no significant effect on the symptoms of the central nervous system.

51-15-0 12
Pralidoxime chloride
Organophosphates.
Name Description Content CAS NO. Registered Holders
Organophosphates

After entering the body, it combines with cholinesterase to form phosphoacylase, leading to accumulation of acetylcholine and the appearance of poisoning symptoms. Antidotes such as pralidoxime iodide can combine with the phosphoryl group in the phosphocholinesterase to restore the activity of cholinesterase and eliminate muscle tremors and spasms, but have poor effects on salivation and sweating. At the same time, it can directly combine with organophosphates in the blood to generate non-toxic substances for excretion.

More

After entering the body, it combines with cholinesterase to form phosphoacylase, leading to accumulation of acetylcholine and the appearance of poisoning symptoms. Antidotes such as pralidoxime iodide can combine with the phosphoryl group in the phosphocholinesterase to restore the activity of cholinesterase and eliminate muscle tremors and spasms, but have poor effects on salivation and sweating. At the same time, it can directly combine with organophosphates in the blood to generate non-toxic substances for excretion.

0
Atropine sulfate tablets (opened)
Main ingredient: Atropine. Chemical name: α-(Hydroxymethyl)phenylacetic acid 8-methyl-8-azabicyclo[3,2,1]-3-octyl ester sulfate monohydrate Molecular weight: (C17H23NO3)2·H2SO4·H2O
Name Description Content CAS NO. Registered Holders
Atropine

No specific pharmacological information is provided

More

No specific pharmacological information is provided

51-55-8 6
Sulfamethoxazole
Name Description Content CAS NO. Registered Holders
Sulfamethoxazole

Extract from the above information

More

Extract from the above information

723-46-6 33
tetracycline
The main component of this product is tetracycline. Its chemical name is 6-methyl-4-(dimethylamino)-3,6,10,12,12α-pentahydroxy-1,11-dioxo-1,4,4α,5,5α,6,11,12α-octahydro-2-naphthacenecarboxamide. Molecular formula: C22H24N2O8. Molecular weight: 444.44.
Name Description Content CAS NO. Registered Holders
Tetracycline

This product is a broad-spectrum antibacterial agent with bactericidal effect at high concentrations. In addition to common Gram-positive bacteria, Gram-negative bacteria and anaerobic bacteria, most Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria and spirochetes are also sensitive to this product. This product is better than Gram-positive bacteria for Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, etc. are sensitive to this product. This product has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant gonococci are also resistant to tetracycline. This product has good antibacterial effect on Gram-negative bacteria such as Vibrio, Yersinia pestis, Brucella, Campylobacter, Yersinia, etc., has no antibacterial activity against Pseudomonas aeruginosa, and has certain antibacterial effect on some anaerobic bacteria.

More

This product is a broad-spectrum antibacterial agent with bactericidal effect at high concentrations. In addition to common Gram-positive bacteria, Gram-negative bacteria and anaerobic bacteria, most Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria and spirochetes are also sensitive to this product. This product is better than Gram-positive bacteria for Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, etc. are sensitive to this product. This product has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant gonococci are also resistant to tetracycline. This product has good antibacterial effect on Gram-negative bacteria such as Vibrio, Yersinia pestis, Brucella, Campylobacter, Yersinia, etc., has no antibacterial activity against Pseudomonas aeruginosa, and has certain antibacterial effect on some anaerobic bacteria.

60-54-8 25
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.